ID: ALA3229632

Max Phase: Preclinical

Molecular Formula: C45H69N11O12S2

Molecular Weight: 1020.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O

Standard InChI:  InChI=1S/C45H69N11O12S2/c1-7-24(4)37-43(67)51-27(14-15-33(46)58)39(63)52-30(19-34(47)59)40(64)54-31(44(68)56-16-8-9-32(56)42(66)53-28(17-23(2)3)38(62)49-21-35(48)60)22-69-70-45(5,6)20-36(61)50-29(41(65)55-37)18-25-10-12-26(57)13-11-25/h10-13,23-24,27-32,37,57H,7-9,14-22H2,1-6H3,(H2,46,58)(H2,47,59)(H2,48,60)(H,49,62)(H,50,61)(H,51,67)(H,52,63)(H,53,66)(H,54,64)(H,55,65)/t24-,27-,28-,29-,30-,31-,32-,37-/m0/s1

Standard InChI Key:  IZIWNJRAVSDMFB-VNHOCEMUSA-N

Associated Targets(Human)

Oxytocin receptor 1962 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Oxytocin receptor 839 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1020.25Molecular Weight (Monoisotopic): 1019.4569AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Lowbridge J, Manning M, Seto J, Haldar J, Sawyer WH..  (1979)  Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.,  22  (5): [PMID:458806] [10.1021/jm00191a019]
2. Hruby VJ, Deb KK, Yamamoto DM, Hadley ME, Chan WY..  (1979)  [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor.,  22  (1): [PMID:423185] [10.1021/jm00187a002]
3. Manning M, Lowbridge J, Seto J, Haldar J, Sawyer WH..  (1978)  [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.,  21  (2): [PMID:621712] [10.1021/jm00200a007]
4. Bankowski K, Manning M, Haldar J, Sawyer WH..  (1978)  Design of potent antagonists of the vasopressor response to arginine-vasopressin.,  21  (9): [PMID:722751] [10.1021/jm00207a002]

Source